Bass Gregory Brooks 4
4 · Lipocine Inc. · Filed Dec 6, 2017
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Bass Gregory Brooks
EVP and Chief Commercial Offic
Transactions
- Award
Stock Options (Right to Buy)
2017-12-06$3.52/sh+75,000$264,000→ 75,000 totalExercise: $3.52From: 2018-12-06Exp: 2027-12-06→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 6, 2018, while the remaining 2/3 of the shares subject to the award have vesting monthly on a prorata basis over the following two years.